Dr. Monica Lynette Guzman-Limon, MD

Dr. Guzman-Limon practices at Satellite Wellbound Austin in San Jose, California.

Dr. Guzman-Limon's NPI, 1659691368, was assigned on June 3, 2010. Dr. Guzman-Limon graduated from UTMB Health in 2010. Dr. Guzman-Limon's Texas license number on file is R4973.

Dr. Guzman-Limon's primary practice is Satellite Wellbound Austin, at 300 Santana Row, San Jose, CA 95128 in Santa Clara County. The practice phone is (512) 833-6695.

Dr. Guzman-Limon's primary practice is Satellite Wellbound Austin in San Jose, California. Dr. Guzman-Limon is also affiliated with St. David's Medical Center. The medical group on file is Central Texas Kidney Associates. Dmand AI also links Dr. Guzman-Limon to 4 more hospitals, 2 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guzman-Limon practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Guzman-Limon's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Guzman-Limon is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Guzman-Limon's licenses on file in 2 states: Texas and Arizona.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Guzman-Limon treats.

CMS data shows 990 Medicare services from Dr. Guzman-Limon across 10 procedure codes in 2024, for 333 Medicare patients. Medicare paid $88,045 for them.

CMS counts 333 Medicare patients who saw Dr. Guzman-Limon in 2024. The largest group is 65 to 74, with 111 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 16% are also on Medicaid. Their average risk score is 4.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guzman-Limon's median patient age at 66, with 54% women.

In 2024, Dr. Guzman-Limon wrote 1,194 Medicare Part D claims for 169 patients. 86% of them were for generic drugs. CMS names the drug for 1,006 of them, across 32 drugs with 11 or more claims each, at $218,033 in total drug cost. In 2023, CMS named 848 claims across 30 drugs.

Dr. Guzman-Limon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Guzman-Limon as offering telehealth.

Dmand AI links 4 papers to Dr. Guzman-Limon, published from 2017 to 2022. Dr. Guzman-Limon's most frequent co-authors are Joshua A. Samuels, MD, Subha Laxmi Amatya, MD and Joseph T. Flynn, MD.

CMS Open Payments shows 73 general payments to Dr. Guzman-Limon from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 57% of the total. Fresenius USA Marketing, Inc. paid the most, $1,729.

Dr. Guzman-Limon graduated from UTMB Health in 2010.

Dr. Guzman-Limon is in network with 20 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.